Mycophenolic Acid Delayed-Release Tablets and Vumerity
Determining the interaction of Mycophenolic Acid Delayed-Release Tablets and Vumerity and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: The use of diroximel fumarate or dimethyl fumarate with other immunosuppressive or myelosuppressive agents may increase the risk of infections. Both diroximel fumarate and dimethyl fumarate alone may cause lymphopenia and serious infections, and the risk may theoretically be increased due to additive immune system effects in the presence of other myelo- or immunosuppressive therapies. MANAGEMENT: The safety and efficacy of diroximel fumarate or dimethyl fumarate in combination with other immunosuppressive agents have not been evaluated. Until further information is available, the use of diroximel fumarate or dimethyl fumarate with other immunosuppressive or myelosuppressive agents should be avoided. References "Product Information. Vumerity (diroximel fumarate)." Alkermes, Inc, Cambridge, MA.
Professional:GENERALLY AVOID: The use of diroximel fumarate or dimethyl fumarate with other immunosuppressive or myelosuppressive agents may increase the risk of infections. Both diroximel fumarate and dimethyl fumarate alone may cause lymphopenia and serious infections, and the risk may theoretically be increased due to additive immune system effects in the presence of other myelo- or immunosuppressive therapies.
MANAGEMENT: The safety and efficacy of diroximel fumarate or dimethyl fumarate in combination with other immunosuppressive agents have not been evaluated. Until further information is available, the use of diroximel fumarate or dimethyl fumarate with other immunosuppressive or myelosuppressive agents should be avoided.
- "Product Information. Vumerity (diroximel fumarate)." Alkermes, Inc, Cambridge, MA.
Generic Name: mycophenolic acid
Brand name: Myfortic
Synonyms: Mycophenolic acid, Mycophenolate Tablets Delayed Release
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mycophenolic Acid Delayed-Release Tablets-Vumon
- Mycophenolic Acid Delayed-Release Tablets-Vusion
- Mycophenolic Acid Delayed-Release Tablets-Vyfemla
- Mycophenolic Acid Delayed-Release Tablets-Vyleesi
- Mycophenolic Acid Delayed-Release Tablets-Vyleesi Injection
- Mycophenolic Acid Delayed-Release Tablets-VyLibra
- Vumerity-Mycophenolic Acid Tablets
- Vumerity-Mycostatin (Nystatin Oral Suspension)
- Vumerity-Mycostatin (Nystatin Tablets and Capsules)
- Vumerity-Mycostatin Suspension
- Vumerity-Mydayis
- Vumerity-Mydayis ER Capsules